Borderline personality disorder

New England Journal of Medicine

Volumn 364, Issue 21, 2011, Pages 2037-2042

  Gunderson, John G ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; OLANZAPINE; SEROTONIN UPTAKE INHIBITOR; PSYCHOTROPIC AGENT;

ARTICLE; AUTOMUTILATION; BORDERLINE STATE; CHILD NEGLECT; CLINICAL FEATURE; DIABETES MELLITUS; DIALECTICAL BEHAVIOR THERAPY; ENVIRONMENTAL FACTOR; FAMILY CONFLICT; HEALTH CARE COST; HEREDITY; HUMAN; HYPERTENSION; IMPULSIVENESS; LIFE EVENT; MAJOR DEPRESSION; MENTALIZATION BASED THERAPY; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PSYCHODYNAMICS; PSYCHOTHERAPY; PSYCHOTRAUMA; SEX DIFFERENCE; SUICIDE ATTEMPT; TRANSFERENCE FOCUSED PSYCHOTHERAPY; ADULT; FEMALE; GENETICS; PSYCHOLOGICAL ASPECT; REMISSION; REVIEW;

ADULT; BORDERLINE PERSONALITY DISORDER; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; REMISSION INDUCTION;

EID: 79957497011     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1007358     Document Type: Article

References (49)

1. Gross R, Olfson M, Gameroff M, et al. Borderline personality disorder in primary care. Arch Intern Med 2002;162:53-60. (Pubitemid 34073401)
2. Gunderson JG, Links PS. Borderline personality disorder: a clinical guide. 2nd ed. Washington, DC: American Psychiatric Press, Inc., 2008.
3. Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM-IV personality disorders in the national comorbidity survey replication. Biol Psychiatry 2007;62:553-64. (Pubitemid 47314365)
4. Grant BF, Chou SP, Goldstein RB, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry 2008;69:533-45. (Pubitemid 351792327)
5. Pascual JC, Córcoles D, Castaño J, et al. Hospitalization and pharmacotherapy for borderline personality disorder in a psychiatric emergency service. Psychiatr Serv 2007;58:1199-204. (Pubitemid 47507960)
6. Bender DS, Dolan RT, Skodol AE, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry 2001; 158:295-302. (Pubitemid 32116528)
7. Zanarini MC, Frankenburg FR, Hennen J, Silk KR. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry 2004;65:28-36.
8. Grilo CM, Sanislow CA, Skodol AE, et al. Longitudinal diagnostic efficiency of DSM-IV criteria for borderline personality disorder: a 2-year prospective study. Can J Psychiatry 2007;52:357-62. (Pubitemid 46997309)
9. Zimmerman M, Mattia JI. Differences between clinical and research practices in diagnosing borderline personality disorder. Am J Psychiatry 1999;156:1570-4. (Pubitemid 29459989)
10. Zimmerman M, Ruggero CJ, Chelminski I, Young D. Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder. J Clin Psychiatry 2010;71:26-31.
11. Groves JE. Borderline personality disorder. N Engl J Med 1981;305:259-62.
12. Vaillant GE. The beginning of wisdom is never calling a patient a borderline. J Psychother Pract Res 1992;1:117-34.
13. Distel MA, Willemsen G, Ligthart L, et al. Genetic covariance structure of the four main features of borderline personality disorder. J Pers Disord 2010;24:427-44.
14. Gunderson JG, Zanarini MC, Choi-Kain LW, Mitchell KS, Jang KK, Hudson JI. Family study of borderline personality disorder and its sectors of psychopathology. Arch Gen Psychiatry (in press).
15. Kupper N, Willemsen G, Riese H, Posthuma D, Boomsma DI, de Geus EJ. Heritability of daytime ambulatory blood pressure in an extended twin design. Hypertension 2005;45:80-5. (Pubitemid 40066418)
16. Donegan NH, Sanislow CA, Blumberg HP, et al. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry 2003;54:1284-93. (Pubitemid 37464873)
17. Silbersweig D, Clarkin JF, Goldstein M, et al. Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. Am J Psychiatry 2007;164:1832-41. (Pubitemid 351739236)
18. King-Casas B, Sharp C, Lomax-Bream L, Lohrenz T, Fonagy P, Montague PR. The rupture and repair of cooperation in borderline personality disorder. Science 2008;321:806-10.
19. Stanley B, Siever LJ. The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psychiatry 2010;167:24-39.
20. Gunderson JG, Stout RL, McGlashan TH, et al. Ten year course of borderline personality disorder: psychopathology and function: from the Collaborative Longitudinal Personality Disorders Study. Arch Gen Psychiatry 2011 April 4 (Epub ahead of print).
21. Rothrock J, Lopez I, Zweilfer R, Andress-Rothrock D, Drinkard R, Walters N. Borderline personality disorder and migraine. Headache 2007;47:22-6. (Pubitemid 46096053)
22. Palmer NB, Salcedo J, Miller AL, Winiarski M, Arno P. Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. AIDS Patient Care STDS 2003;17:635-44. (Pubitemid 38031551)
23. Massion AO, Dyck IR, Shea MT, Phillips KA, Warshaw MG, Keller MB. Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder. Arch Gen Psychiatry 2002;59:434-40. (Pubitemid 34477678)
24. Walter M, Gunderson JG, Zanarini MC, et al. New onsets of substance use disorders in borderline personality disorder over 7 years of follow-ups: findings from the Collaborative Longitudinal Personality Disorder Study. Addiction 2009;104:97-103.
25. Soeteman DI, Hakkaart-van Roijen L, Verheul R, Busschbach JJ. The economic burden of personality disorders in mental health care. J Clin Psychiatry 2008;69:259-65. (Pubitemid 351469269)
26. Sansone RA, Lam C, Wiederman MW. Road rage: relationships with borderline personality and driving citations. Int J Psychiatry Med 2010;40:21-9.
27. Tweed RG, Dutton DG. A comparison of impulsive and instrumental subgroups of batterers. Violence Vict 1998;13:217-30. (Pubitemid 28531706)
28. Trestman RL, Ford J, Zhang W, Wiesbrock V. Current and lifetime psychiatric illness among inmates not identified as acutely mentally ill at intake in Connecticut's jails. J Am Acad Psychiatry Law 2007;35:490-500.
29. Fernández Montalvo J, Echeburúa E. Pathological gambling and personality disorders: a pilot study with the MCMI-II. Psicothema 2006;18:453-8. (In Spanish.)
30. Gunderson JG, Lyons-Ruth K. BPD's interpersonal hypersensitivity phenotype: a gene-environment-developmental model. J Pers Disord 2008;22:22-41. (Pubitemid 351469286)
31. Winograd G, Cohen P, Chen H. Adolescent borderline symptoms in the community: prognosis for functioning over 20 years. J Child Psychol Psychiatry 2008;49:933-41.
32. Goodman M, Patil U, Triebwasser J, et al. Parental viewpoints of trajectories to borderline personality disorder in female offspring. J Pers Disord 2010;24:204-16.
33. Zanarini MC, Frankenburg FR. A preliminary, randomized trial of psychoeducation for women with borderline personality disorder. J Pers Disord 2008;22:284-90.
34. Oldham JM, Gabbard GO, Goin MK, et al. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 2001;158:Suppl:1-52.
35. Weinberg I, Ronningstam E, Goldblatt MJ, Schechter M, Maltsberger JT. Common factors in empirically supported treatments of borderline personality disorder. Curr Psychiatry Rep 2011;13:60-8.
36. Binks CA, Fenton M, McCarthy L, Lee T, Adams CE, Duggan C. Psychological therapies for people with borderline personality disorder: the Cochran Collaboration. New York: Wiley, 2007.
37. Linehan MM, Comtois KA, Murray AM, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 2006;63:757-66. [Erratum, Arch Gen Psychiatry 2007;64:1401.]
38. Linehan MM, Heard HL. Borderline personality disorder: costs, course and treatment outcomes. In: Miller N, Magruder N, eds. The cost-effectiveness of psychotherapy: a guide for practitioners, researchers and policy makers. New York: Oxford University Press, 1999:291-305.
39. Bateman A, Fonagy P. Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. Am J Psychiatry 2003;160:169-71. (Pubitemid 36042443)
40. McMain SF, Links PS, Gnam WH, et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry 2009;166:1365-74. [Erratum, Am J Psychiatry 2010;167:1283.]
41. Gunderson JG, Bender D, Sanislow C, et al. Plausibility and possible determinants of sudden "remissions" in borderline patients. Psychiatry 2003;66:111-9.
42. Weinberg I, Ronningstam E, Goldblatt MJ, Schechter M, Wheelis J, Maltsberger JT. Strategies in treatment of suicidality: identification of common and treatment-specific interventions in empirically supported treatment manuals. J Clin Psychiatry 2010;71:699-706.
43. Hoffman PD, Fruzzetti AE, Buteau E, et al. Family connections: a program for relatives of persons with borderline personality disorder. Fam Process 2005;44:217-25. (Pubitemid 40816333)
44. Gunderson JG, Lyoo IK. Family problems and relationships for adults with borderline personality disorder. Harv Rev Psychiatry 1997;4:272-8. (Pubitemid 27086602)
45. Gunderson JG, Morey LC, Stout RL, et al. Major depressive disorder and borderline personality disorder revisited: longitudinal interactions. J Clin Psychiatry 2004;65:1049-56.
46. Ingenhoven T, Lafay P, Rinne T, Passchier J, Duivenvoorden H. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Clin Psychiatry 2010;71:14-25.
47. Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry 2010;196:4-12.
48. Waldinger RJ, Frank AF. Transference and the vicissitudes of medication use by borderline patients. Psychiatry 1989;52:416-27. (Pubitemid 20005940)
49. Frankenburg FR, Zanarini MC. Obesity and obesity-related illnesses in borderline patients. J Pers Disord 2006;20:71-80.